Robin X Luo
Impact in
- Oncology top 2%
- Cancer-related Molecular Pathways
- Molecular Biology top 5%
- Epigenetics and DNA Methylation
- Genomics and Chromatin Dynamics
- Ubiquitin and proteasome pathways
- Histone Deacetylase Inhibitors Research
- Chromatin Remodeling and Cancer
- RNA modifications and cancer
Papers in
- Oncology 3
- Cancer-related Molecular Pathways 3
- Co-authors
- Douglas C. DeanAntonio PostigoJ. William HarbourSteven J. WeintraubSong HeDuanduan MaAnjali DahiyaLiise‐anne Pirofski
- Journals
- Cell (3 papers)Nature (1 paper)Biotechnology and Bioengineering (1 paper)Infection and Immunity (1 paper)Molecular and Cellular Biology (1 paper)
- Partner nations
- United StatesBrazilFrance
In The Last Decade
Robin X Luo
9 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Oncology 1.5k
- Molecular Biology 2.2k
- Cell Biology 352
- Ophthalmology 184
- Aging 33
Countries citing papers authored by Robin X Luo
This map shows the geographic impact of Robin X Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin X Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin X Luo more than expected).
Fields of papers citing papers by Robin X Luo
This network shows the impact of papers produced by Robin X Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin X Luo. The network helps show where Robin X Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Robin X Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 13 | |
| 2 | 2005 | 28 | |
| 3 | 2004 | 14 | |
| 4 | 2004 | 44 | |
| 5 | 2000 | 139 | |
| 6 | Exit from G1 and S Phase of the Cell Cycle Is Regulated by Repressor Complexes Containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF Hit paper breakdown → | 2000 | 540 |
| 7 | Cdk Phosphorylation Triggers Sequential Intramolecular Interactions that Progressively Block Rb Functions as Cells Move through G1 Hit paper breakdown → | 1999 | 835 |
| 8 | Rb Interacts with Histone Deacetylase to Repress Transcription Hit paper breakdown → | 1998 | 819 |
| 9 | 1995 | 430 |
About Robin X Luo
Robin X Luo is a scholar working on Ophthalmology, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 9 papers that have together received 2.9k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (4 papers), Cancer-related Molecular Pathways (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Chromatin Remodeling and Cancer (2 papers), Genomics and Chromatin Dynamics (2 papers), Protein purification and stability (2 papers), Toxin Mechanisms and Immunotoxins (1 paper) and Virus-based gene therapy research (1 paper). The work is most often cited by research in Oncology (1.5k citations), Molecular Biology (2.2k citations), Cell Biology (352 citations), Ophthalmology (184 citations) and Aging (33 citations). Robin X Luo has collaborated with scholars based in United States, Brazil and France. Frequent co-authors include Douglas C. Dean, Antonio Postigo, J. William Harbour, Steven J. Weintraub, Song He, Duanduan Ma, Anjali Dahiya, Liise‐anne Pirofski, Krishanthi Subramaniam and Robert W. Maitta. Their work appears in journals such as Cell, Nature, Biotechnology and Bioengineering, Infection and Immunity and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.